A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)

Name: A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)
Published: 2014
License: Public Domain

Institut Curie · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

multiplemyeloma relapse transplantation

multiple myeloma, first relapse, myeloma, relapse, refractory, pcd, ifm/dfci 2009, transplantation, autologous, pomalidomide, immunoglobulin, ig

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)

Related documents